Author Question: On which of the following pharmacological dimensions does cannabis (delta-9-THC) differ ... (Read 41 times)

scienceeasy

  • Hero Member
  • *****
  • Posts: 565
On which of the following pharmacological dimensions does cannabis (delta-9-THC) differ significantly from LSD, psilocybin and mescaline?
 
  a. the degree to which they induce profound and intense perceptual distortions and hallucinatory experiences
  b. their effects on wakefulness
  c. the rate at which tolerance develops to their subjective effects
  d. all of these

Question 2

The major psychoactive compound in marijuana, delta-9-THC, has actions mediated by CB1 receptors. An endogenous ligand for this class of receptors is called
 
  a. dopamine
  b. serotonin
  c. acetylcholine
  d. anandamide



xiaomengxian

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

d

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The modern decimal position system was the invention of the Hindus (around 800 AD), involving the placing of numerals to indicate their value (units, tens, hundreds, and so on).

Did you know?

The most common childhood diseases include croup, chickenpox, ear infections, flu, pneumonia, ringworm, respiratory syncytial virus, scabies, head lice, and asthma.

Did you know?

Pubic lice (crabs) are usually spread through sexual contact. You cannot catch them by using a public toilet.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

For a complete list of videos, visit our video library